Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Study Purpose
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Recruitment Criteria
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
Eligible Ages | 12 Years and Over |
Gender | All |
Inclusion Criteria for participants coming from a parent study: Participants must meet all the following criteria to be eligible for this study:
- - Received treatment in a lebrikizumab study, NCT04146363, NCT04178967, NCT04250337, NCT04250350 and have adequately completed the study treatments and last patient visit of the parent trial.
- - For women of childbearing potential: agree to remain abstinent (refrain from heterosexual intercourse) or use a highly effective contraceptive method during the treatment period and for at least 18 weeks after the last dose of lebrikizumab or placebo.
- - Participants who, during their participation in the parent trial, developed a serious adverse event (SAE) deemed related to lebrikizumab, which in the opinion of the investigator or of the medical monitor could indicate that continued treatment with lebrikizumab may present an unreasonable risk for the participant.
- - Participants who, during their participation in the parent trial, developed an AE that was deemed related to lebrikizumab and led to study treatment discontinuation, which in the opinion of the investigator or of the medical monitor could indicate that continued treatment with lebrikizumab may present an unreasonable risk for the participant.
- - Conditions in the previous parent study consistent with protocol-defined criteria for permanent study drug discontinuation, if deemed related to lebrikizumab or led to investigator - or sponsor-initiated withdrawal of participant from the study (e.g., non-compliance, inability to complete study assessments, etc.).
- - Pregnant or breastfeeding women, or women planning to become pregnant or breastfeed during the study.
Inclusion Criteria:
Participants must meet all the following criteria to be eligible for this study addendum:- - Male or female adults and adolescents (≥12 to <18 years of age and weighing ≥40 kilogram (kg).
- - Chronic AD (according to American Academy of Dermatology Consensus Criteria) that has been present for ≥1 year before screening.
- - Eczema Area and Severity Index (EASI) score ≥16 at baseline.
- - Investigator Global Assessment (IGA) score ≥3 (scale of 0 to 4) at baseline.
- - ≥10% body surface area (BSA) of AD involvement at baseline.
- - History of inadequate response to treatment with topical medications; or determination that topical treatments are otherwise medically inadvisable.
Exclusion Criteria:
Participants meeting any of the criteria below will be excluded from this study addendum:- - Have received a dose of lebrikizumab in any prior lebrikizumab clinical study.
- - History of anaphylaxis.
- - Treatment with topical prescription moisturizers, corticosteroids, calcineurin inhibitors, or phosphodiesterase-4 inhibitors such as crisaborole within 1 week prior to baseline.
- - Treatment with any of the following agents within 4 weeks prior to the baseline.
- - Immunosuppressive/immunomodulating drugs (e.g., systemic corticosteroids, cyclosporine, mycophenolate-mofetil, Interferon gamma (IFN-γ), Janus kinase inhibitors, azathioprine, methotrexate, etc.) - Phototherapy and photochemotherapy (PUVA) for AD.
- - Treatment with the following prior to baseline: - Immunosuppressive/immunomodulating drugs (e.g., systemic corticosteroids, cyclosporine, mycophenolate-mofetil, IFN-γ, Janus kinase inhibitors, azathioprine, methotrexate, etc.) - Phototherapy and photochemotherapy (PUVA) for AD.
- - Treatment with the following prior to baseline: - An investigational drug within 8 weeks or within 5 half-lives (if known), whichever is longer.
- - B Cell-depleting biologics, including rituximab, within 6 months.
- - Other Biologics within 5 half-lives (if known) or 8 weeks, whichever is longer.
- - Regular use (more than 2 uses per week) of a tanning booth/parlor within 4 weeks of baseline.
- - Treatment with a live (attenuated) vaccine within 12 weeks of the baseline or planned during the study.
- - Uncontrolled chronic disease that might require multiple intermittent uses of oral corticosteroids, e.g., co-morbid severe uncontrolled asthma, (as defined by the investigator).
- - Pregnant or breastfeeding women, or women planning to become pregnant or breastfeed during the study.
- - Evidence of active acute or chronic hepatitis.
- - History of human immunodeficiency virus (HIV) infection or positive HIV serology at screening.
- - History of malignancy, including mycosis fungoides, within 5 years before screening, except completely treated in situ carcinoma of the cervix, completely treated and resolved non-metastatic squamous or basal cell carcinoma of the skin with no evidence of recurrence in the past 12 weeks.
Inclusion Criteria:
Have completed Week 100 of Study KGAA and have not yet completed the safety follow-up visit for the main study. Open-Label Extension AddendumExclusion Criteria:
Have initiated treatment with a medication prohibited by Study KGAA before addendum baseline. This includes use of biologics for AD (for example, dupilumab and tralokinumab) during the safety follow-up period of Study KGAA.Trial Details
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT04392154 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 3 |
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
Eli Lilly and Company |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) |
Principal Investigator Affiliation | Eli Lilly and Company |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Industry |
Overall Status | Active, not recruiting |
Countries | Australia, Bulgaria, Canada, Estonia, France, Germany, Korea, Republic of, Latvia, Lithuania, Mexico, Poland, Singapore, Spain, Taiwan, Ukraine, United States |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Atopic Dermatitis |
Participants who have completed participation in a Dermira- or Lilly-sponsored lebrikizumab study (parent study), DRM06-AD04, DRM06-AD05, DRM06-AD06, DRM06-AD17 or DRM06- AD18, will be offered the opportunity to enroll in this study. Participants may either be blinded or not blinded, depending on their parent study assignment. This study will also be open to an additional approximately 100 participants in the United States (addendum) who have not completed participation in a Dermira- or Lilly-sponsored lebrikizumab study. Treatment will not be blinded. This study will also include an Addendum to extend the study treatment period by an additional 32 weeks and to add a treatment arm testing dosing every 8 weeks. This Addendum will apply to existing study participants in selected countries. Treatment will not be blinded.
Arms
Experimental: Lebrikizumab Q2W (Open-Label) from Parent Study
Participants assigned to lebrikizumab Q2W (once every 2 weeks) arm will receive investigational product Q2W by subcutaneous (SC) injection.
Experimental: Lebrikizumab Q2W (Blinded) from Parent Study
Participants assigned to lebrikizumab Q2W arm will receive investigational product Q2W by SC injection. Some participants will receive loading doses.
Experimental: Lebrikizumab Q2W (Open-Label Addendum)
Participants enrolling in Open-Label Addendum will receive lebrikizumab Q2W by SC injection after loading doses.
Experimental: Lebrikizumab Q4W
Participants assigned to lebrikizumab Q4W (once every 4 weeks) arm will receive investigational product Q4W by SC injection. Intervention assigned: Lebrikizumab balanced with Placebo to maintain the blind between treatment arms.
Experimental: Lebrikizumab Q4W (Open-Label Extension Addendum)
Participants enrolling in Open-Label extension addendum will receive lebrikizumab Q4W by SC injection.
Experimental: Lebrikizumab Q8W (Open-Label Extension Addendum)
Participants enrolling in Open-Label extension addendum will receive lebrikizumab Q8W by SC injection.
Experimental: Lebrikizumab Q2W (Open-Label Extension Addendum)
Participants enrolling in Open-Label extension addendum will receive lebrikizumab Q2W by SC injection.
Interventions
Biological: - Lebrikizumab
Subcutaneous injection
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
Pinnacle Research Group, LLC
Anniston, Alabama, 36207
Status
Address
Clinical Research Center of Alabama- Birmingham
Birmingham, Alabama, 35244
Status
Address
Investigate MD
Scottsdale, Arizona, 85255
Status
Address
Johnson Dermatology
Fort Smith, Arkansas, 72916
Status
Address
Burke Pharmaceutical Research
Hot Springs, Arkansas, 71913
Status
Address
Arkansas Research Trials
North Little Rock, Arkansas, 72117
Status
Address
Northwest Arkansas Clinical Trials Center
Rogers, Arkansas, 72758
Status
Address
Orange County Research Institute
Anaheim, California, 92801
Status
Address
Bakersfield Dermatology and Skin Cancer Medical Group
Bakersfield, California, 93309
Status
Address
Wallace Medical Group, Inc.
Beverly Hills, California, 90211
Status
Address
Hope Clinical Research, Inc.
Canoga Park, California, 91303
Status
Address
California Dermatology & Clinical Research Institute
Encinitas, California, 92024
Status
Address
First OC Dermatology
Fountain Valley, California, 92708
Status
Address
MD Studies
Fountain Valley, California, 92708
Status
Address
Center For Dermatology Clinical Research, Inc.
Fremont, California, 94538
Status
Address
Axon Clinical Research
Inglewood, California, 90301
Status
Address
Sunwise Clinical Research
Lafayette, California, 94549
Status
Address
Avance Trials
Laguna Niguel, California, 92677
Status
Address
California Allergy and Asthma Medical Group + Research Center
Los Angeles, California, 90025
Status
Address
Keck School of Medicine University of Southern California
Los Angeles, California, 90033
Status
Address
Dermatology Research Associates
Los Angeles, California, 90045
Status
Address
LA Universal Research Center, INC
Los Angeles, California, 90057
Status
Address
Ablon Skin Institute and Research Center
Manhattan Beach, California, 90266
Status
Address
Dermatology Clinical Trials
Newport Beach, California, 92660
Status
Address
Cura Clinical Research
Palmdale, California, 93551
Status
Address
MD Strategies Research Centers MDSRC
Poway, California, 92064
Status
Address
Integrative Skin Science and Research
Sacramento, California, 95815
Status
Address
Integrative Skin Science and Research
Sacramento, California, 95825
Status
Address
Therapeutics Clinical Research
San Diego, California, 92123
Status
Address
University Clinical Trials
San Diego, California, 92123
Status
Address
University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology
San Diego, California, 92123
Status
Address
Synergy Dermatology
San Francisco, California, 94132
Status
Address
Care Access Research
San Jose, California, 95117
Status
Address
San Luis Dermatology & Laser Clinic
San Luis Obispo, California, 93405
Status
Address
Southern California Dermatology, Inc.
Santa Ana, California, 92701
Status
Address
IMMUNOe International Research Centers
Centennial, Colorado, 80112
Status
Address
Asthma and Allergy Associates, PC
Colorado Springs, Colorado, 80907-6231
Status
Address
Central Connecticut Dermatology
Cromwell, Connecticut, 06416
Status
Address
Medical Faculty Associates, Inc.
Washington, District of Columbia, 20016
Status
Address
George Washington University Medical Center
Washington, District of Columbia, 20037
Status
Address
St. Francis Medical Institute
Clearwater, Florida, 33765
Status
Address
Florida Academic Centers Research and Education, LLC
Coral Gables, Florida, 33134
Status
Address
Pediatric Skin Research, LLC
Coral Gables, Florida, 33146
Status
Address
Clinical Physiology Associates
Fort Myers, Florida, 33912
Status
Address
The University of Florida Health System
Gainesville, Florida, 32606
Status
Address
Direct Helpers Research Center
Hialeah, Florida, 33012
Status
Address
The Community Research of South Florida
Hialeah, Florida, 33016
Status
Address
Encore Medical Research
Hollywood, Florida, 33021
Status
Address
Solutions Through Advanced Research
Jacksonville, Florida, 32256
Status
Address
GSI Clinical Research, LLC
Margate, Florida, 33063
Status
Address
C & R Research Services USA
Miami Beach, Florida, 33169
Status
Address
Wellness Clinical Research
Miami Lakes, Florida, 33016
Status
Address
Vitae Research Center, LLC
Miami, Florida, 33135
Status
Address
Acevedo Clinical Research Associates
Miami, Florida, 33142
Status
Address
International Dermatology Research, Inc.
Miami, Florida, 33144
Status
Address
Community Research Foundation Inc
Miami, Florida, 33145
Status
Address
Sanchez Clinical Research Inc
Miami, Florida, 33157
Status
Address
Miami Dermatology and Laser Research
Miami, Florida, 33173
Status
Address
Well Pharma Medical Research Corp.
Miami, Florida, 33173
Status
Address
Florida Research Center, Inc
Miami, Florida, 33174
Status
Address
Tory Sullivan, MD PA
North Miami Beach, Florida, 33162
Status
Address
Park Avenue Dermatology
Orange Park, Florida, 32073
Status
Address
Riverchase Dermatology and Cosmetic Surgery
Pembroke Pines, Florida, 33028
Status
Address
ForCare Clinical Research
Tampa, Florida, 33613-1244
Status
Address
Olympian Clinical Research
Tampa, Florida, 33614
Status
Address
University of South Florida College of Medicine
Tampa, Florida, 33620
Status
Address
Georgia Pollens Clinical Research Centers, Inc
Albany, Georgia, 31707
Status
Address
IACT Health - VHC
Columbus, Georgia, 31904
Status
Address
Marietta Dermatology Clinical Research
Marietta, Georgia, 30060
Status
Address
Advanced Medical Research
Sandy Springs, Georgia, 30328
Status
Address
Georgia Skin & Cancer Clinic
Savannah, Georgia, 31419
Status
Address
Northwestern University
Chicago, Illinois, 60611
Status
Address
Sneeze, Wheeze, & Itch Associates LLC
Normal, Illinois, 61761
Status
Address
Arlington Dermatology
Rolling Meadows, Illinois, 60008
Status
Address
Northshore University Healthsystem
Skokie, Illinois, 60077
Status
Address
Dundee Dermatology
West Dundee, Illinois, 60118
Status
Address
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250
Status
Address
The Indiana Clinical Trials Center
Plainfield, Indiana, 46168
Status
Address
Epiphany Dermatology of Kansas, LLC
Overland Park, Kansas, 66210
Status
Address
Kansas Medical Clinic, an Elligo Health Research, Inc.
Shawnee Mission, Kansas, 66216
Status
Address
Kansas Medical Clinic
Topeka, Kansas, 66614
Status
Address
Skin Sciences, PLLC
Louisville, Kentucky, 40217
Status
Address
Meridian Clinical Research
Baton Rouge, Louisiana, 70808
Status
Address
Tulane Univ School of Med
New Orleans, Louisiana, 70112
Status
Address
Dermatology and Skin Cancer Specialists, LLC
Rockville, Maryland, 20850
Status
Address
ActivMed Practices and Research
Beverly, Massachusetts, 01915
Status
Address
Tufts Medical Center
Boston, Massachusetts, 02111
Status
Address
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Status
Address
Metro Boston Clinical Partners
Brighton, Massachusetts, 02135
Status
Address
Beacon Clinical Research, LLC
Quincy, Massachusetts, 02169
Status
Address
Fivenson Dermatology
Ann Arbor, Michigan, 48103
Status
Address
Oakland Dermatology
Auburn Hills, Michigan, 48326
Status
Address
Great Lakes Research Group, Inc.
Bay City, Michigan, 48706
Status
Address
Michigan Center for Research Company
Clarkston, Michigan, 48346
Status
Address
Henry Ford Hospital
Detroit, Michigan, 48202
Status
Address
St Joseph Dermatology and Vein Clinic
Saint Joseph, Michigan, 49085
Status
Address
Associated Skin Care Specialists
Fridley, Minnesota, 55432
Status
Address
Associated Skin Care Specialists
New Brighton, Minnesota, 55112
Status
Address
MediSearch Clinical Trials
Saint Joseph, Missouri, 64506
Status
Address
Central Dermatology PC
Saint Louis, Missouri, 63117
Status
Address
Advanced Dermatology of the Midlands
Omaha, Nebraska, 68144
Status
Address
JDR Dermatology Research
Las Vegas, Nevada, 89148
Status
Address
ALLCUTIS Research
Portsmouth, New Hampshire, 03801
Status
Address
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey, 08520
Status
Address
Skin Laser and Surgery Specialists, a Division of Schweiger Dermatology
Hackensack, New Jersey, 07601
Status
Address
Montefiore Medical Center
Bronx, New York, 10467-2490
Status
Address
Forest Hills Dermatology Group
Kew Gardens, New York, 11415
Status
Address
JUVA Skin & Laser Center
New York, New York, 10022-3350
Status
Address
Icahn Sch of Med at Mt. Sinai
New York, New York, 10029
Status
Address
Sadick Research Group
New York, New York, 10075
Status
Address
Advanced Asthma and Allergy
Watertown, New York, 13601
Status
Address
OnSite Clinical Solutions
Charlotte, North Carolina, 28277
Status
Address
Medication Management
Greensboro, North Carolina, 27408
Status
Address
Wake Research Associates
Raleigh, North Carolina, 27612
Status
Address
Wilmington Dermatology Center
Wilmington, North Carolina, 28405
Status
Address
University Hospitals Case Medical Center
Cleveland, Ohio, 44106
Status
Address
Ohio Pediatric Research Association
Dayton, Ohio, 45414
Status
Address
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112
Status
Address
Unity Clinical Research
Oklahoma City, Oklahoma, 73118
Status
Address
Central States Research
Tulsa, Oklahoma, 74136
Status
Address
Vital Prospects Clinical Research Institute, PC
Tulsa, Oklahoma, 74136
Status
Address
Crisor, LLC, Medford office
Medford, Oregon, 97504
Status
Address
Oregon Dermatology and Research Center
Portland, Oregon, 97210
Status
Address
Oregon Medical Research Center
Portland, Oregon, 97223
Status
Address
OHSU Center for Health and Healing
Portland, Oregon, 97239
Status
Address
The Pennsylvania Centre for Dermatology, LLC
Exton, Pennsylvania, 19341
Status
Address
Paddington Testing Company Inc
Philadelphia, Pennsylvania, 19103
Status
Address
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104
Status
Address
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213
Status
Address
DermDox Dermatology Centers
Sugarloaf, Pennsylvania, 18249
Status
Address
Peak Research LLC
Upper Saint Clair, Pennsylvania, 15241
Status
Address
Clinical Partners, LLC
Johnston, Rhode Island, 02919
Status
Address
AAPRI Clinical Research Institute
Warwick, Rhode Island, 02886
Status
Address
Palmetto Clinical Trial Services, LLC
Anderson, South Carolina, 29621
Status
Address
Clinical Research Center of the Carolinas
Charleston, South Carolina, 29407
Status
Address
Medical University of South Carolina
Charleston, South Carolina, 29425
Status
Address
Rivergate Dermatology Clinical Research Center PL
Goodlettsville, Tennessee, 37072
Status
Address
Arlington Research Center, Inc
Arlington, Texas, 76011
Status
Address
Bellaire Dermatology Associates
Bellaire, Texas, 77401
Status
Address
Dermatology Treatment and Research Center
Dallas, Texas, 75230
Status
Address
Modern Research Associates
Dallas, Texas, 75231
Status
Address
Austin Institute for Clinical Research
Dripping Springs, Texas, 78620
Status
Address
Innovate Research, LLC
Fort Worth, Texas, 76244
Status
Address
Center for Clinical Studies
Houston, Texas, 77004
Status
Address
Suzanne Bruce and Associates, PA
Houston, Texas, 77056
Status
Address
Encore Imaging & Medical Research
Houston, Texas, 77065
Status
Address
Cutis Wellness Dermatology
Laredo, Texas, 78041
Status
Address
Laredo Dermatology Associates P.A.
Laredo, Texas, 78041
Status
Address
Austin Institute for Clinical Research
Pflugerville, Texas, 78660
Status
Address
Progressive Clinical Research
San Antonio, Texas, 78213
Status
Address
Texas Dermatology and Laser Specialists
San Antonio, Texas, 78218
Status
Address
Acclaim Dermatology PLLC
Sugar Land, Texas, 77479
Status
Address
Center for Clinical Studies
Webster, Texas, 77598
Status
Address
University of Utah MidValley Dematology
Murray, Utah, 84107
Status
Address
Velocity Clinical Research - Woseth Dermatology
Salt Lake City, Utah, 84117
Status
Address
Jordan Valley Dermatology Center
West Jordan, Utah, 84088
Status
Address
PI-Coor Clinical Research, LLC
Burke, Virginia, 22015
Status
Address
Virginia Clinical Research, Inc.
Norfolk, Virginia, 23502
Status
Address
Dermatology Associates of Seattle
Seattle, Washington, 98101
Status
Address
Premier Clinical Research
Spokane, Washington, 99202
International Sites
Status
Address
Woden Dermatology
Phillip, Australian Capital Territory, 2606
Status
Address
The Skin Hospital
Darlinghurst, New South Wales, 02010
Status
Address
Premier Specialists Pty Ltd
Kogarah, New South Wales, 2217
Status
Address
The St. George Hospital
Kogarah, New South Wales, 2217
Status
Address
Holdsworth House Medical Practice
Sydney, New South Wales, 2010
Status
Address
Skin & Cancer Foundation Australia
Westmead, New South Wales, 2045
Status
Address
Westmead Hospital
Westmead, New South Wales, 2145
Status
Address
The Skin Centre
Benowa, Queensland, 4217
Status
Address
University of the Sunshine Coast Clinical Trial Centre
Sippy Downs, Queensland, 04556
Status
Address
Veracity Clinical Research Pty Ltd
Woolloongabba, Queensland, 4102
Status
Address
Clinical Trials SA Pty Ltd
Hectorville, South Australia, 5073
Status
Address
Emeritus Research
Camberwell, Victoria, 3124
Status
Address
Skin Health Institute Inc.
Carlton, Victoria, 3053
Status
Address
Sinclair Dermatology
Melbourne, Victoria, 3002
Status
Address
The Royal Melbourne Hospital
Parkville, Victoria, 03050
Status
Address
Royal Children's Hospital
Parkville, Victoria, 3052
Status
Address
Fremantle Dermatology
Fremantle, Western Australia, 6160
Status
Address
Burswood Dermatology
Victoria Park, Western Australia, 06100
Status
Address
Captain Stirling Medical Centre
Nedlands, , 6009
Status
Address
DCC Sveti Georgi
Haskovo, , 6300
Status
Address
Diagnostic and Consultation Center 14
Sofia, , 1408
Status
Address
Alexandrovska University Hospital
Sofia, , 1431
Status
Address
Euro Derma clinic
Sofia, , 1606
Status
Address
Military Medical Academy
Sofia, , 1606
Status
Address
Medical centre Alitera-Med EOOD
Sofia, , 1618
Status
Address
Dermatology Research Institute
Calgary, Alberta, T2J 7E1
Status
Address
CARe Clinic
Red Deer, Alberta, T4P1K4
Status
Address
Dr. Chih-ho Hong Medical Inc.
Surrey, British Columbia, V3R 6A7
Status
Address
Enverus Medical Research
Surrey, British Columbia, V3V 0C6
Status
Address
University of British Columbia
Vancouver, British Columbia, V5Z 4E8
Status
Address
Wiseman Dermatology Research Inc.
Winnipeg, Manitoba, R3M 3Z4
Status
Address
CCA Medical Research
Ajax, Ontario, L1S7K8
Status
Address
Simcoderm Medical & Surgical Dermatology Centre
Barrie, Ontario, L4M 7G1
Status
Address
Skin Health
Cobourg, Ontario, K9A 0Z4
Status
Address
Lynderm Research Inc.
Markham, Ontario, L3P 1X2
Status
Address
North York Research Inc.
North York, Ontario, M2M4J5
Status
Address
The Centre for Clinical Trials, Inc
Oakville, Ontario, L6J7W5
Status
Address
Ottawa Allergy Research Corp
Ottawa, Ontario, K1G 6C6
Status
Address
Dermatology Ottawa Research Centre
Ottawa, Ontario, K2C 3N2
Status
Address
The Centre for Dermatology
Richmond Hill, Ontario, L4B 1A5
Status
Address
AvantDerm
Toronto, Ontario, M5A3R6
Status
Address
K. Papp Clinical Research
Waterloo, Ontario, N2J 1C4
Status
Address
International Dermatology Research
Montreal, Quebec, H3H1V4
Status
Address
Vahlberg & Pild OU
Talinn, , 10134
Status
Address
Kliiniliste uuringute Keskus OU
Tartu, , 50160
Status
Address
Tartu University Hospital
Tartu, , 51417
Status
Address
CHU de Bordeaux Hop St ANDRE
Bordeaux, Gironde, 33075
Status
Address
CHRU de Brest - Hôpital Morvan
Brest, , 29200
Status
Address
CHU Dijonon
Dijon, , 21079
Status
Address
CHD Vendee
La Roche sur Yon, , 85000
Status
Address
Cabinet Médical
Martigues, , 13500
Status
Address
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
Nantes, , 44093
Status
Address
CHU de Nice Hopital de L'Archet
Nice, , 06202
Status
Address
Hopital Saint Louis
Paris, , 75010
Status
Address
Hopital Larrey
Toulouse cedex 9, , 31059
Status
Address
Studienzentrum Dr.Beate Schwarz
Langenau, Baden-Württemberg, 89129
Status
Address
Hautarztpraxis am Löwenmarkt
Stuttgart, Baden-Württemberg, 70499
Status
Address
Dermazentrum Augsburg
Augsburg, Bayern, 86179
Status
Address
Rosenpark Research GmbH
Darmstadt, Hessen, 64283
Status
Address
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt am Main, Hessen, 60596
Status
Address
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt, Hesse, 60590
Status
Address
Klinische Forschung Osnabrück
Osnabrück, Lower Saxony, 49074
Status
Address
Fachklinik Bad Bentheim
Bad Bentheim, Niedersachsen, 48455
Status
Address
Elbe Klinikum Buxtehude
Buxtehude, Niedersachsen, 21614
Status
Address
Hautzentrum im Jahrhunderthaus
Bochum, Nordrhein-Westfalen, 44793
Status
Address
Universitätsklinikum Münster - Albert Schweitzer Campus
Münster, Nordrhein-Westfalen, 48149
Status
Address
Company for Medical Study & Service Selters GmbH
Selters, Rheinland-Pfalz, 56242
Status
Address
Hautarztpraxis Dr. Gerlach
Dresden, Sachsen, 01097
Status
Address
Universität Leipzig - Universitätsklinikum
Leipzig, Sachsen, 04103
Status
Address
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus - Klinik und Poliklinik fuer
Dresden, Saxony, 01307
Status
Address
Velocity Clinical Research Leipzig GmbH
Leipzig, Saxony, 04103
Status
Address
SRH Wald-Klinikum Gera
Gera, Thüringen, 07548
Status
Address
Praxis Dr. med. Virgil-Oreste Mihaescu Facharzt fr Dermatologie und STD
Augsburg, , 86150
Status
Address
Charité Campus Virchow-Klinikum
Berlin, , 10117
Status
Address
ISA GmbH
Berlin, , 10789
Status
Address
Praxis für Ganzheitliche Dermatologie im Ärztehaus
Berlin, , 13055
Status
Address
Dermatologikum Hamburg
Hamburg, , 20144
Status
Address
TFS Trial Support Form GmbH
Hamburg, , 20537
Status
Address
Soon Chun Hyang University Bucheon Hospital
Bucheon, Gyeonggi-do, 14584
Status
Address
Ajou University Hospital
Suwon, Gyeonggi-do, 16499
Status
Address
Pusan National University Hospital
Busan, Korea, 49241
Status
Address
Hanyang University Medical Center
Seoul, Korea, 04763
Status
Address
Asan Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], 05505
Status
Address
Hallym University Kangnam Sacred Heart Hospital
Seoul, Seoul-teukbyeolsi [Seoul], 07441
Status
Address
Korea University Ansan Hospital
Gyeonggi-do, , 15355
Status
Address
Incheon St. Mary's Hospital
Incheon, , 21431
Status
Address
Severance Hospital, Yonsei University Health System
Seoul, , 03722
Status
Address
Konkuk University Medical Center
Seoul, , 05030
Status
Address
Chung-Ang University Hospital
Seoul, , 06973
Status
Address
Clinic of Dermatology and STD
Riga, , LV-1001
Status
Address
Health and Aesthetics LTD
Riga, , LV-1009
Status
Address
Latvian Dermatology Institute
Riga, , LV-1011
Status
Address
Health Center 4, Affiliate Diagnostic Center
Riga, , LV1003
Status
Address
Smite Aija - Doctor Practice in Dermatology Venereology
Talsi, , LV-3201
Status
Address
JSC "CD8 Alergology Clinic"
Kaunas, , LT-44192
Status
Address
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, , LT-50161
Status
Address
Children's Hospital, Affiliate of Vilnius University Hospital Santaros klinikos
Vilnius, , 08406
Status
Address
Jsc Renmeda
Vilnius, , LT-07195
Status
Address
JSC "Center for Diagnosis and Treatment of Allergic Diseases"
Vilnius, , LT-08109
Status
Address
JSC Inlita (Santaros CTC)
Vilnius, , LT-08406
Status
Address
Vilnius University Hospital Santaros Klinikos
Vilnius, , LT-08441
Status
Address
Hospital Infantil de Mexico Federico Gomez
Ciudad de Mexico, Federal District, 06720
Status
Address
Grupo Clinico CATEI Sociedad Civil
Guadalajara, Jalisco, 44657
Status
Address
Clinica De Enfermedades Cronicas y Procedimientos Especiales
Morelia, Michoacan, 58249
Status
Address
Cemdeicy S.C.P.
Merida, Yucatán, 97130
Status
Address
Derma Norte del Bajio
Aguascalientes, , 20130
Status
Address
Arke Estudios Clinicos S.A. de C.V.
Veracruz, , 91910
Status
Address
dermMedica Sp. z o.o.
Wrocław, Dolnośląskie, 51-503
Status
Address
Dermoklinika Centrum Medyczne s.c. M. Kierstan J. Narbutt A. Lesiak
Lodz, Lodzkie, 90-436
Status
Address
Grazyna Pulka Specjalistyczny Osrodek "ALL-MED"
Krakow, Malopolskie, 30-033
Status
Address
Diamond Clinic
Krakow, Malopolskie, 31-559
Status
Address
Centrum Medyczne Evimed
Warsaw, Mazowieckie, 02-625
Status
Address
Centralny Szpital Kliniczny MSWiA
Warszawa, Mazowieckie, 02-507
Status
Address
Labderm s.c.
Ossy, Slaskie, 42-624
Status
Address
Clinica Vitae Sp. z o.o.
Gdansk, Woj. Pomorskie, 80-344
Status
Address
Zespol Naukowo - Leczniczy "Iwolang" Sp. z o.o.
Iwonicz Zdroj, Wojewodztwo Podkarpackie, 38-440
Status
Address
Laser Clinic Dermatologia Laserowa Medycyna Estetyczna
Szczecin, Zachodniopomorskie, 70-332
Status
Address
Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Ploszczuk
Bialystok, , 15-369
Status
Address
Wojewodzki Szpital Zespolony
Elblag, , 82-300
Status
Address
Oddzial Dermatologii COPERNICUS
Gdansk, , 80-462
Status
Address
Centrum Badan Klinicznych PI-House sp. z o.o.
Gdynia, , 81-553
Status
Address
Holsamed
Katowice, , 40-600
Status
Address
Gabinet Dermatlogiczny. Beata Krecisz
Kielce, , 25-155
Status
Address
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie
Lublin, , 20-081
Status
Address
Centrum Alergologii Teresa Hofman
Poznan, , 60-214
Status
Address
Kliniczny Szpital Wojewodzki nr. 1 Klinika Dermatologii
Rzeszow, , 35-055
Status
Address
Twoja Przychodnia - Szczecinskie Centrum Medyczne
Szczecin, , 71 500
Status
Address
Alergo-Med Specjalistyczna Przychodnia Lekarska Sp Z O.O.
Tarnow, , 33-100
Status
Address
Clinical Research Group Sp. z o.o.
Warszawa, , 01-142
Status
Address
High-Med Prywatny Gabinet Lekarski
Warszawa, , 01-817
Status
Address
MTZ Clinical Research Sp.z.o.o.
Warszawa, , 02-106
Status
Address
Klinika Ambroziak Sp. Z.O.O.
Warszawa, , 02-953
Status
Address
CityClinic Przychodnia Lekarsko-Psychologiczna
Wroclaw, , 50-566
Status
Address
Centrum Medyczne Angelius Provita
Katowice, Śląskie, 40-611
Status
Address
National University Hospital
Singapore, Central Singapore, 119074
Status
Address
Singapore General Hospital
Singapore, , 169078
Status
Address
Kk Women'S and Childrens Hospital
Singapore, , 229899
Status
Address
National Skin Centre NSC
Singapore, , 308205
Status
Address
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona [Barcelona], 8950
Status
Address
Hospital Germans Trias i Pujol
Badalona, Catalunya [Cataluña], 08916
Status
Address
Hospital General Universitario de Alicante
Alicante, , 03010
Status
Address
Hospital Clinic de Barcelona
Barcelona, , 08036
Status
Address
Hospital de la Santa Creu i Sant Pau
Barcelona, , 08041
Status
Address
Hospital Universitario Basurto
Bilbao (Bizkaia), , 48013
Status
Address
Hospital Universitario Infanta Leonor-INTERNAL MED
Madrid, , 28031
Status
Address
Hospital Universitario Virgen Macarena
Sevilla, , 41009
Status
Address
Kaohsiung Chang Gung Memorial Hospital
Niaosong, Kaohsiung City, 833
Status
Address
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung, , 80756
Status
Address
Taipei Medical University Shuang Ho Hospital
New Taipei, , 23561
Status
Address
Chung Shan Medical University Hospital
Taichung, , 402
Status
Address
China Medical University Hospital
Taichung, , 40447
Status
Address
National Taiwan University Hospital
Taipei, , 10002
Status
Address
Chang Gung Memorial Hospital - Linkou
Taoyuan City, , 33305
Status
Address
Community Institution Zaporizhzhya Regional Dermatovenereology Clinical Hospital of Zaporizhzhya Regional Council
Poshtova Square 2, Zaporizhzhya, 69063
Status
Address
Municipal Healthcare Institution Kharkiv City Dermatoverenologic Dispensary N2
Kharkiv, , 61038
Status
Address
SE "Institute of Dermatology and Venerology of NAMS of Ukraine"
Kharkiv, , 61057
Status
Address
Rivne Regional Dermatology and Venereology Dispensary
Rivne, , 33028
Status
Address
Treatment-diagnostic center PE "Asclepius"
Uzhhorod, , 88000